Study Guide to Substance Abuse Treatment

A Companion to The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Fifth Edition

Philip R. Muskin, M.D.

2016
419 Pages

ISBN 978-1-58562-511-6
Item #62511

List Price: $61.00
APA Members: $48.80
APA Resident-Fellow Members: $45.75

Description
Contents
Contributors
About the Authors

Study Guide to Substance Abuse Treatment is a question-and-answer companion that allows you to evaluate your mastery of the subject matter as you progress through The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Fifth Edition. The Study Guide is made up of questions divided into individual quizzes of 10-20 questions each that correspond to the chapters in the Textbook. Questions are followed by an Answer Guide that references relevant text (including the page number) in the Textbook to allow quick access to needed information. Each answer is accompanied by a discussion that addresses the correct response and also (when appropriate) explains why other responses are not correct.

Contributors
Preface
Part I: Questions
Chapter 1. Neurobiology of Addiction
Chapter 2. Genetics of Addiction
Chapter 3. Epidemiology of Addiction
Chapter 4. Cross-Cultural Aspects of Addiction
Chapter 5. Science in the Treatment of Substance Abuse
Chapter 6. Assessment of the Patient
Chapter 7. Screening and Brief Intervention
Chapter 8. Patient Placement Criteria
Chapter 9. Recovery in Chronic Care Disease Management: Disease Control in Substance Use Disorders
Chapter 10. Neurobiology of Alcohol Use Disorder
Chapter 11. Treatment of Alcohol Intoxication and Alcohol Withdrawal
Chapter 12. Neurobiology of Stimulants
Chapter 13. Clinical Management: Cocaine
Chapter 14. Clinical Management: Methamphetamine
Chapter 15. Hallucinogens and Club Drugs
Chapter 16. Tobacco Use Disorder
Chapter 17. Benzodiazepines and Other Sedatives and Hypnotics
Chapter 18. Treatment of Anabolic-Androgenic Steroid–Related Disorders
Chapter 19. Neurobiology of Opiates and Opioids
Chapter 20. Opioid Detoxification
Chapter 21. Methadone and Buprenorphine Maintenance
Chapter 22. Opioid Antagonists
Chapter 23. Neurobiology of Marijuana
Chapter 24. Treatment of Cannabis Use Disorder
Chapter 25. Psychodynamic Psychotherapy
Chapter 26. Cognitive-Behavioral Therapies
Chapter 27. Motivational Enhancement
Chapter 28. Twelve-Step Facilitation: An Adaptation for Psychiatric Practitioners and Patients
Chapter 29. Contingency Management
Chapter 30. Network Therapy
Chapter 31. Group Therapy
Chapter 32. Family Therapy
Chapter 33. Inpatient Treatment
Chapter 34. Therapeutic Communities
Chapter 35. Community-Based Treatment
Chapter 36. History of Alcoholics Anonymous and the Experiences of Patients
Chapter 37. Psychological Mechanisms in Alcoholics Anonymous
Chapter 38. Outcomes Research on Twelve-Step Programs
Chapter 39. Women and Addiction
Chapter 40. Perinatal Substance Use Disorders
Chapter 41. Adolescent Substance Use Disorders: Epidemiology, Neurobiology, and Screening
Chapter 42. Adolescent Substance Use Disorders: Transition to Substance Abuse, Prevention, and Treatment
Chapter 43. Psychiatric Consultation in Pain and Addiction
Chapter 44. Prevention of Prescription Drug Abuse
Chapter 45. HIV/AIDS and Hepatitis C
Chapter 46. Substance Use Disorders Among Physicians
Chapter 47. Substance Use Issues Among Lesbian, Gay, Bisexual, and Transgender People
Chapter 48. Minorities
Chapter 49. Testing to Identify Recent Drug Abuse
Chapter 50. Medical Education on Addiction
Chapter 51. Prevention of Substance Abuse
Chapter 52. Forensic Addiction Psychiatry
Chapter 53. Substance Abuse and Mental Illness

Philip R. Muskin, M.D., is Professor of Psychiatry at Columbia University Medical Center; Chief of Consultation-Liaison Psychiatry at New York–Presbyterian Hospital/Columbia Campus; and on the faculty of the Columbia University Center for Psychoanalytic Training and Research in New York, New York.